Day One Biopharmaceuticals, Inc. Gains 65.88%
Fri, Mar 06, 2026 at 07:26 PM
Day One Biopharmaceuticals, Inc. (DAWN:NASDAQ) jumped higher at $21.2, a gain of 65.9%. On Fri, Mar 06, 2026, DAWN:NASDAQ hit a New 2-Week High of $21.2. The stock got featured on our News Catalysts scanner on Fri, Mar 06, 2026 at 03:27 PM in the 'ACQUISITION' category. From Fri, Feb 20, 2026, the stock recorded 30.00% Up Days and 54.55% Green Days
About Day One Biopharmaceuticals, Inc. (DAWN:NASDAQ)
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company.
Top 10 Gainers:
- Peraso Inc. (PRSO:NASDAQ), 151.54%
- Decent Holding Inc. (DXST:NASDAQ), 83.61%
- Edesa Biotech, Inc. (EDSA:NASDAQ), 80.61%
- AN2 Therapeutics, Inc. (ANTX:NASDAQ), 66.67%
- Day One Biopharmaceuticals, Inc. (DAWN:NASDAQ), 65.88%
- Cre8 Enterprise Limited (CRE:NASDAQ), 65.33%
- Epsium Enterprise Limited (EPSM:NASDAQ), 64.15%
- Silynxcom Ltd. (SYNX:NYSEMKT), 57.99%
- N2OFF, Inc. (NITO:NASDAQ), 38.64%
- Cohen & Company Inc. (COHN:NYSEMKT), 36.23%